May 17, 2020

Are medical practices waiting too long for costly Hepatitis C treatments?

3 min
Are medical practices waiting too long for costly Hepatitis C treatments.jpg
Written by Alyssa Clark The pricing war has caused health insurers, medical practices and patients to band together to demand better access to these l...

Written by Alyssa Clark


The pricing war has caused health insurers, medical practices and patients to band together to demand better access to these life-saving drugs.

Drugs from Sovaldi and Olysio are now offering promising solutions for those suffering from hepatitis C, however the recently released lifesavers can cost upwards of $1,000 per pill. This cost has caused rippling results for taxpayers and healthcare providers alike, because when patient costs go up, so does the need for patient financial aid, government health programs and providers’ purchasing expenses.  This “waiting game” is not only irresponsible to protecting public health, but causes unwarranted pressure on medical practices and businesses as an entire unit:

“The price makes it very hard for the healthcare system,” said Steve Pearson, who oversaw the meeting Monday for the California Technology Assessment Forum, a group affiliated with health insurers that holds public meetings to weigh evidence on new treatments.

The system as a whole entity is being affected by this pricing-spike; it’s not only the patients who are affronted with outrageous out-of-pocket charges. Until recently, therapies for hepatitis C were only 50 percent successful in treating patients and housed numerous side effects such as flu-like symptoms, anemia and even depression. With the recently released drugs from Sovaldi and Olysio, cure rates are proven to skyrocket to the 80th and 90th percentile and will present users with fewer amounts of uncomfortable or harmful side effects.

The only thing holding back patients from receiving these revolutionary drugs is the price. On top of patients facing the immediate burden of the out-of-pocket costs, providers are feeling the financial-heat from the spike as well. Medi-Cal insurers, private practices and corporate healthcare businesses are all sensitive to the hep C pricing and are worrisome of an expensive trend sparking in the industry:

“I can’t imagine how that would be feasible without bankrupting our system,” said Rena K. Fox, a professor of medicine at the University of California, San Francisco, invited by the forum to speak as an outside expert.

“What I really wish for is that we could push back on the price, rather than make patients wait. But since we don’t have the ability to change the price, we have to decide which patients are the most urgent.”

Making both patients and providers wait until the pricing battle ceases not only puts patients’ lives in danger, but causes providers to continue to prescribe these 40 percent effective treatments, when a 90 percent effective treatment exists within reach. In addition to these already unfortunate circumstances, physicians have to now decide “who deserves the drug most”, forcing those sick patients to wait until their conditions worsens enough to make it onto the pre-approved list.  

Although pharma giants like Johnson & Johnson, Sovaldi, Gilead and others work with government health programs and low-income patients, employers and health insurers are worried that these are only the first to come of these high-priced specialty drugs, and what the healthcare industry will begin to look like as a result of this expensive pharmaceutical drug-market.



Share article

Mar 30, 2021

LG launches purpose-built smart TV for hospitals

smart tv
video call
Leila Hawkins
2 min
LG launches purpose-built smart TV for hospitals
LG's new smart TVs have been designed to safely improve the patient experience...

LG Business Solutions USA has announced two new hospital TVs that are designed to improve patient management and engagement while adhering to critical safety standards for healthcare facilities.

One of the TVs is LG's biggest ever screen for a hospital - the 65-inch 4K Ultra HD model. It has LG’s NanoCell display technology, enabling it to display vivid pictures, and provides built-in support for hospital pillow speakers and embedded broadband LAN capability, so hospitals can deliver video on demand without requiring a separate set-top box in the patient room.

 It also includes configuration software with an intuitive interface for setting up the TV to work in a hospital setting, plus a software-enabled access point feature that turns the TV into a Wi-Fi hotspot. 

The second TV screen is the 15-inch Personal Healthcare Smart Touch TV with a multi-touch screen. It is designed to be installed on an adjustable arm for use in shared spaces or smaller patient rooms and will support LG's new, modular LG AM-AC21EA video camera, and HD video communication.

Both include support for video conferencing, and are UL Certified for use in healthcare facilities, a global safety standard. They also feature LG’s integrated Pro:Centric hospital management solutions, allowing hospitals and LG’s patient engagement development partners to personalise a patient's room, providing entertainment, hospital information, services, patient education, and more. 

Additionally its communication platform makes it possible to conduct video calls between patients and clinicians or family.

“Our newest LG hospital TVs reflect ongoing feedback from the industry and include capabilities integrated to meet the unique needs of a critical market” said Tom Mottlau, Director of Healthcare Solutions, LG Electronics USA.

“Our healthcare patient engagement development partners requested an upgradable version of webOS for our Pro:Centric smart TV platform so they could more easily introduce new features for their hospital customers. For the latest versions of webOS, LG worked closely with our partners to make their request a reality and to deliver a hospital TV platform that can evolve over time.”

Share article